Transgenic Mice

Patent No. EP3209698 (titled "Transgenic Mice") was filed by Crescendo Biologics on Oct 22, 2014. The application was issued on Feb 9, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSJun 5, 2019J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3209698

CRESCENDO BIOLOGICS
Application Number
EP14790686A
Filing Date
Oct 22, 2014
Status
Patent Maintained As Amended
Jan 7, 2022
Publication Date
Feb 9, 2022